The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Damulin I.V.

kafedra nervnykh bolezneĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Stepkina D.A.

Lokshina A.B.

Neyromidin in mixed vascular and Alzheimers dementia

Authors:

Damulin I.V., Stepkina D.A., Lokshina A.B.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(2): 40‑43

Read: 6450 times

Download PDF (RU)
Contact the author
Table of contents

NEYROMIDIN IN MIXED VASCULAR AND ALZHEIMERS DEMENTIA
NEYROMIDIN IN MIXED VASCULAR AND ALZHEIMERS DEMENTIA

To cite this article:

Damulin IV, Stepkina DA, Lokshina AB. Neyromidin in mixed vascular and Alzheimers dementia. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(2):40‑43. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Como­rbidity of depression and deme­ntia: epidemiological, biological and therapeutic aspe­cts. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):113-121
The rela­tionship between neuropsychological indi­cators and neuroimaging changes acco­rding to MRI morphometry in patients with Alzheimer’s disease and glaucoma. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):142-152
Non-invasive biomarkers for early diagnosis of Alzheimer’s disease in bodily fluids. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):8-16
The expe­rience of diagnosing Alzheimer’s disease based on the study of cere­brospinal fluid biomarkers. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):91-97
Neurobiological pote­ntial of astragaloside IV and prospects for its use in the treatment of Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):7-12
Animal expe­rimental models in the study of age-dependent cere­bral microangiopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):57-68
Cyto­kine status of patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):5-12
Curcumin-induced increased reti­nal fluorescence as a new method in the early diagnosis of Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):19-25
Differential diagnosis of Alzheimer’s disease and vascular cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):26-35
A comprehensive study of Alzheimer’s disease biomarkers in plasma and cere­brospinal fluid. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):43-53
Abstract:

The efficacy of neyromidin (ipidacrinum), a nonselective inhibitor of acetylcholinesterase and butyrilcholinesterase was studied in patients with mixed vascular and Alzheimers dementia of mild and moderate severity. Thirty patients of the main group received neyromidin in dosage 80 mg/day during 3 months; 10 patients of the comparison group matched by age, sex and severity of cognitive disorders did not receive the drug. The positive effect was seen in 53,3% of patients of the main group. The worsening was observed in 40% of patients of the comparison group. The positive effect of the drug on spatial and neurodynamic functions was revealed. No serious side-effects of the treatment were found.

Keywords:

mixed dementia
vascular dementia
Alzheimers disease
acetylcholinesterase inhibitors
ipidacrinum

Authors:

Damulin I.V.

kafedra nervnykh bolezneĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Stepkina D.A.

Lokshina A.B.

Close metadata

References:

  1. Bukatina E.E., Grigor'eva I.V., Sokol'chik E.I. Effektivnost' amiridina pri senil'noi dementsii al'tsgeimerovskogo tipa. Zhurn nevropatol i psikh 1991; 91: 9: 53-58.
  2. Bukatina E.E., Smirnov O.R., Grigor'eva I.V. Effektivnost' amiridina pri mul'tiinfarktnoi dementsii. Sotsial'naya i klinicheskaya psikhiatriya 1992; 2: 126-133.
  3. Bukatina E.E., Grigor'eva I.V., Smirnov O.R. Sopostavlenie vliyaniya amiridina na mul'tiinfarktnuyu dementsiyu i senil'nuyu dementsiyu al'tsgeimerovskogo tipa. Sotsial'naya i klinicheskaya psikhiatriya 1994; 4: 2: 100-105.
  4. Gavrilova S.I. Farmakoterapiya bolezni Al'tsgeimera. M: Pul's 2003; 109-115.
  5. Golovkova M.S., Zakharov V.V., Lifshits M.Yu., Yakhno N.N. Primenenie neiromidina v terapii sosudistykh kognitivnykh narushenii raznoi vyrazhennosti. Zhurn nevrologii i psikh 2007; 107: 9: 20-26.
  6. Damulin I.V. Bolezn' Al'tsgeimera i sosudistaya dementsiya. Pod red. N.N. Yakhno. M 2002; 85.
  7. Damulin I.V., Zakharov V.V., Mkhitaryan E.A., Koberskaya N.N. Opyt primeneniya galantamina (reminila) pri sosudistoi i smeshannoi dementsii. Nevrol zhurn 2005; 10: 5: 30-35.
  8. Katunina E.A. Primenenie ipidakrina v vosstanovitel'nom periode ishemicheskogo insul'ta. Rus med zhurn 2008; 16: 12: 1-6.
  9. Levin O.S. Diagnostika i lechenie dementsii v klinicheskoi praktike. M: MEDpress-inform 2010; 256.
  10. Mkhitaryan E.A. Znachenie sosudistykh tserebral'nykh narushenii pri bolezni Al'tsgeimera: Avtoref. dis. … kand. med. nauk. M 2004.
  11. Mkhitaryan E.A., Preobrazhenskaya I.S. Bolezn' Al'tsgeimera i tserebrovaskulyarnye rasstroistva. Nevrol zhurn 2006; 11: 1: 31-37.
  12. Preobrazhenskaya I.S. Ekselon v terapii neirodegenerativnykh dementsii. Nevrol zhurn 2006; 11: 1: 42-47.
  13. Preobrazhenskaya I.S., Yakhno N.N. Sosudistye kognitivnye narusheniya: klinicheskie proyavleniya, diagnostika, lechenie. Nevrol zhurn 2007; 12: 5: 45-50.
  14. Yakhno N.N. Aktual'nye voprosy neirogeriatrii. V sb.: Dostizheniya v neirogeriatrii. Pod red. N.N. Yakhno, I.V. Damulina. M 1995; 1: 9-29.
  15. Yakhno N.N., Preobrazhenskaya I.S. Lechenie neirodegenerativnykh dementsii. Consilium medicum 2004; 6: 12: 935-943.
  16. Yakhno N.N. Kognitivnye rasstroistva v nevrologicheskoi klinike. Nevrol zhurn 2006; 11: Prilozhenie 1: 4-12.
  17. Yakhno N.N., Zakharov V.V., Lokshina A.B. i dr. Dementsii. Rukovodstvo dlya vrachei. 2-e izdanie. M: MEDpress-inform 2010; 272.
  18. Birks J. Cholinesterase inhibitors for Alzheimers disease. Cochrane Database Syst Rev 2006; Issue 1: CD005593.
  19. Craiq D., Birks J. Galantamine for vascular cognitive impairment. Cochrane Database Syst Rev 2006; Issue 1: CD004746.
  20. Damaerschalck B.M., Winqerchuk D.M. Treatment of vascular dementia and vascular cognitive impairment. Neurologist 2007; 13: 37-41.
  21. Erkinjuntti T., Kurz A., Gauthier S. Efficacy of galantamine in probable vascular dementia and Alzheimers disease combined with cerebrovascular disease: a randomized trial. Lancet 2002; 359: 9314: 1283-1290.
  22. Erkinjuntti T., Roman G., Gauthier S. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors. J Neurol Sci 2004; 226: 63-66.
  23. Erkinjuntti T., Roman G., Gauthier S. et al. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke 2004; 35: 1010-1017.
  24. Folstein M.F., Folstein S.E., McHugh P.R. Mini-Mental State; a practical guide for grading the mental state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
  25. Frisoni G.B. Treatment of Alzheimers disease with acetylcholinesterase inhibitors: bridging the gap between evidence and practice. J Neurol 2001; 248: 551-557.
  26. Fu C., Chute D.J., Farag E.S. et al. Comorbidity in dementia: an autopsy study. Arch Pathol Lab Med 2004; 128: 1: 32-38.
  27. Hulette C.M. Brain banking in the United States. J Neuropathol Exp Neurol 2003; 62: 7: 715-722.
  28. Kojima J., Onodera K., Ozeki M., Nakayama K. Ipidacrine (NIK-247): A review of multiple mechanisms as an antidementia agent. CNS Drug Rev 1998; 4: 247-259.
  29. Lezak M.D. Neuropsychology Assessment. New York: New York University Press 1983.
  30. Rockwood K., Macknight C., Wentzel C. et al. The Diagnosis of "mixed" dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC). Ann NY Acad Sci 2000; 903: 522-528.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.